BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32086240)

  • 21. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
    Zhuang Z; Li H; Lee H; Aguilar M; Gocho T; Ju H; Iida T; Ling J; Fu J; Wu M; Sun Y; Lu Y; Chiao PJ
    Cancer Lett; 2017 Dec; 411():44-56. PubMed ID: 28951128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
    Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
    Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
    Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
    Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
    Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
    Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
    Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
    McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
    Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer.
    Honselmann KC; Finetti P; Birnbaum DJ; Monsalve CS; Wellner UF; Begg SKS; Nakagawa A; Hank T; Li A; Goldsworthy MA; Sharma H; Bertucci F; Birnbaum D; Tai E; Ligorio M; Ting DT; Schilling O; Biniossek ML; Bronsert P; Ferrone CR; Keck T; Mino-Kenudson M; Lillemoe KD; Warshaw AL; Fernández-Del Castillo C; Liss AS
    Mol Cancer Res; 2020 Dec; 18(12):1889-1902. PubMed ID: 32873625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function.
    Begum A; McMillan RH; Chang YT; Penchev VR; Rajeshkumar NV; Maitra A; Goggins MG; Eshelman JR; Wolfgang CL; Rasheed ZA; Matsui W
    Pancreas; 2019 Mar; 48(3):329-334. PubMed ID: 30747824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.
    Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M
    Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer.
    Kitamura F; Semba T; Yasuda-Yoshihara N; Yamada K; Nishimura A; Yamasaki J; Nagano O; Yasuda T; Yonemura A; Tong Y; Wang H; Akiyama T; Matsumura K; Uemura N; Itoyama R; Bu L; Fu L; Hu X; Wei F; Mima K; Imai K; Hayashi H; Yamashita YI; Miyamoto Y; Baba H; Ishimoto T
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37733442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
    Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
    Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines.
    Schwörer S; Cimino FV; Ros M; Tsanov KM; Ng C; Lowe SW; Carmona-Fontaine C; Thompson CB
    Cancer Res; 2023 May; 83(10):1596-1610. PubMed ID: 36912618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5.
    Nakajima K; Ino Y; Naito C; Nara S; Shimasaki M; Ishimoto U; Iwasaki T; Doi N; Esaki M; Kishi Y; Shimada K; Hiraoka N
    Br J Cancer; 2022 Mar; 126(4):628-639. PubMed ID: 34824448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer.
    Li YX; Zhu XX; Wu X; Li JH; Ni XH; Li SJ; Zhao W; Yin XY
    Cancer Lett; 2022 Sep; 544():215802. PubMed ID: 35732215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.